A new plasma biomarker clock offers an early glimpse into Alzheimer’s timing, potentially reshaping prevention research and therapeutic trials.In a recent study published in the journal Nature Medicine, researchers developed and validated plasma biomarker-based clock models using plasma %p-tau217 to estimate when cognitively unimpaired individuals with evidence of underlying Alzheimer’s pathology may progress to symptomatic […]
